![Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study | World Journal of Surgical Oncology | Full Text Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1477-7819-12-234/MediaObjects/12957_2014_Article_1912_Fig1_HTML.jpg)
Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study | World Journal of Surgical Oncology | Full Text
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S151684841500170X-fx1.jpg)
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
![Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/939f9e71-c16d-4bf8-9449-da9629dcc93a/mfig001.jpg)
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
![Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies | Journal of Experimental & Clinical Cancer Research | Full Text Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-015-0155-4/MediaObjects/13046_2015_155_Fig1_HTML.gif)
Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies | Journal of Experimental & Clinical Cancer Research | Full Text
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/2-Table1-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S151684841500170X-gr1.jpg)
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-019-0267-8/MediaObjects/41408_2019_267_Fig1_HTML.png)
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
![Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio | Blood Cancer Journal Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-021-00460-0/MediaObjects/41408_2021_460_Fig1_HTML.png)
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio | Blood Cancer Journal
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)